These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review. Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852 [TBL] [Abstract][Full Text] [Related]
9. Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation. Cioffi SM; Galimberti D; Barocco F; Spallazzi M; Fenoglio C; Serpente M; Arcaro M; Gardini S; Scarpini E; Caffarra P J Alzheimers Dis; 2016 Sep; 54(2):717-21. PubMed ID: 27567822 [TBL] [Abstract][Full Text] [Related]
10. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy. Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers. Galimberti D; Bonsi R; Fenoglio C; Serpente M; Cioffi SM; Fumagalli G; Arighi A; Ghezzi L; Arcaro M; Mercurio M; Rotondo E; Scarpini E Brain Behav Immun; 2015 Oct; 49():182-7. PubMed ID: 26021560 [TBL] [Abstract][Full Text] [Related]
12. Early neuropsychological characteristics of progranulin mutation carriers. Hallam BJ; Jacova C; Hsiung GY; Wittenberg D; Sengdy P; Bouchard-Kerr P; Slack P; Rademakers R; Baker M; Chow TW; Levine B; Feldman HH; Mackenzie IR J Int Neuropsychol Soc; 2014 Aug; 20(7):694-703. PubMed ID: 24993774 [TBL] [Abstract][Full Text] [Related]
13. Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin. Caroppo P; Le Ber I; Camuzat A; Clot F; Naccache L; Lamari F; De Septenville A; Bertrand A; Belliard S; Hannequin D; Colliot O; Brice A JAMA Neurol; 2014 Dec; 71(12):1562-6. PubMed ID: 25317628 [TBL] [Abstract][Full Text] [Related]
14. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort. Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257 [TBL] [Abstract][Full Text] [Related]
15. Co-occurrence of the C9ORF72 expansion and a novel GRN mutation in a family with alternative expression of frontotemporal dementia and amyotrophic lateral sclerosis. Testi S; Tamburin S; Zanette G; Fabrizi GM J Alzheimers Dis; 2015; 44(1):49-56. PubMed ID: 25182743 [TBL] [Abstract][Full Text] [Related]
16. From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder. Cerami C; Marcone A; Galimberti D; Villa C; Scarpini E; Cappa SF J Alzheimers Dis; 2011; 27(4):791-7. PubMed ID: 21891869 [TBL] [Abstract][Full Text] [Related]
17. Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation. Gazzina S; Archetti S; Alberici A; Bonomi E; Cosseddu M; Di Lorenzo D; Padovani A; Borroni B J Alzheimers Dis; 2017; 57(4):1185-1189. PubMed ID: 28304311 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia. Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429 [TBL] [Abstract][Full Text] [Related]
19. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease. Carecchio M; Fenoglio C; De Riz M; Guidi I; Comi C; Cortini F; Venturelli E; Restelli I; Cantoni C; Bresolin N; Monaco F; Scarpini E; Galimberti D J Neurol Sci; 2009 Dec; 287(1-2):291-3. PubMed ID: 19683260 [TBL] [Abstract][Full Text] [Related]
20. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency. Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]